Immunocytochemistry with Cytokeratin 19 and Anti-Human Mesothelial Cell Antibody (HBME1) Increases the Diagnostic Accuracy of Thyroid Fine-Needle Aspirations: Preliminary Report of 150 Liquid-Based Fine-Needle Aspirations with Histological Control

被引:76
作者
Cochand-Priollet, Beatrix [1 ]
Dahan, Henri [2 ]
Laloi-Michelin, Marie [3 ]
Polivka, Marc [1 ]
Saada, Michele [1 ]
Herman, Philippe [4 ]
Guillausseau, Pierre-Jean [3 ]
Hamzi, Lounis [2 ]
Pote, Nicolas [1 ]
Sarfati, Emile [5 ]
Wassef, Michel [1 ]
Combe, Herve [6 ]
Raulic-Raimond, Danielle [7 ]
Chedin, Pierre [6 ]
Medeau, Virginie [8 ]
Casanova, Daniele [9 ]
Kania, Romain [4 ]
机构
[1] Lariboisiere Hosp, Dept Cytopathol & Pathol, F-75010 Paris, France
[2] Lariboisiere Hosp, Dept Radiol, F-75010 Paris, France
[3] Lariboisiere Hosp, Dept Endocrinol, F-75010 Paris, France
[4] Lariboisiere Hosp, Dept Laryngol Otol & Cervicofacial Surg, F-75010 Paris, France
[5] Univ Paris 07, St Louis Hosp, AP HP, Dept Surg, Paris, France
[6] Victor Dupouy Hosp Ctr, Dept Endocrinol Diabetol & Nutr, Argenteuil, France
[7] Med Off, Levallois Perret, France
[8] Gen Hosp Ctr, Dept Endocrinol Diabetol & Internal Med, Meaux, France
[9] Heart Ctr N, Paris, France
关键词
BRAF V600E MUTATION; IMMUNOHISTOCHEMICAL MARKERS; CYTOLOGICAL DIAGNOSIS; MALIGNANCY; MANAGEMENT; CARCINOMA; SYNOPSIS; LESIONS; STATE; IMMUNODETECTION;
D O I
10.1089/thy.2011.0014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Thyroid nodules are relatively common (7% of the population) but are malignant in only 5%-10% of cases. Fine-needle aspiration (FNA) to detect cancer can have >90% sensitivity but only 50%-65% specificity because of false-positive results, which necessitates surgical controls. We aimed to assess the diagnostic accuracy of immunocytochemistry (ICC) of thyroid FNA to improve its sensitivity and specificity. Methods: We prospectively collected 2038 thyroid FNAs, of which 1397 were FNA biopsies with liquid-based cytology (Thin-Prep-Hologic (R)). ICC with cytokeratin 19 and HBME1 antibodies (Dako (R) A/S) was used for all malignant cases and cases of atypical cells of undetermined significance (AUS), follicular neoplasm (FN), and nodules suspicious for malignancy-papillary thyroid carcinoma (SM-PTC) as well as some benign cases (abnormal features on radiography or benign on secondary FNA). ICC results were defined as "non-contributory," "favoring benign," "favoring malignant," or "indeterminate." Results for 150 cases were compared with histological controls for diagnostic accuracy. Results: Of these 150 cases ICC was helpful for benign or malignant triage of 48 cases of AUS, FN, and SM-PTC (42% of these lesions). Six (4%) ICC results were false positive (favoring malignant with benign histology) but none were false negative (favoring benign with malignant histology). Results for indeterminate cytological cases favored malignant or benign disease with sensitivity, specificity, and negative and positive predictive values of 100%, 85.2%, 100%, and 86.2%, respectively. Conclusions: ICC of thyroid FNAs with cytokeratin 19 and HBME1 antibodies can reduce the false-positive and false-negative results of single morphological analyses. It can increase the sensitivity and specificity of diagnosis, thus improving diagnostic accuracy and reducing the need for surgical controls.
引用
收藏
页码:1067 / 1073
页数:7
相关论文
共 50 条
  • [1] FNAC Thyroid Reporting Categories: Value of Using the British Thyroid Association (Thy 1 to Thy 5) Thyroid FNAC Reporting Guidelines
    Agarwal, A.
    Kocjan, G.
    [J]. CYTOPATHOLOGY, 2009, 20 (02) : 133 - 134
  • [2] AKERMAN M, 1985, ACTA CYTOL, V29, P850
  • [3] [Anonymous], 1996, ANN ENDOCRINOL-PARIS, V57, P526
  • [4] The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid
    Asa, SL
    [J]. ENDOCRINE PATHOLOGY, 2005, 16 (04) : 295 - 309
  • [5] Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A Synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference
    Baloch, Zubair W.
    LiVolsi, Virginia A.
    Asa, Syl L.
    Rosai, Juan
    Merino, Maria J.
    Randolph, Gregory
    Vielh, Philippe
    DeMay, Richard M.
    Sidawy, Mary K.
    Frable, William J.
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 2008, 36 (06) : 425 - 437
  • [6] Diagnostic value of differential expression of CK19, galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis
    Barroeta, J. E.
    Baloch, Z. W.
    Lal, P.
    Pasha, T. L.
    Zhang, P. J.
    LiVolsi, V. A.
    [J]. ENDOCRINE PATHOLOGY, 2006, 17 (03) : 225 - 234
  • [7] Fine needle aspiration cytology of thyroid nodules: how accurate is it and what are the causes of discrepant cases?
    Cappel, RJDTN
    Bouvy, ND
    Bonjer, HJ
    Van Muiswinkel, JM
    Chadha, S
    [J]. CYTOPATHOLOGY, 2001, 12 (06) : 399 - 405
  • [8] Continuing controversies in the management of thyroid nodules
    Castro, MR
    Gharib, H
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (11) : 926 - 931
  • [9] Cheung Y. S., 2007, Hong Kong Medical Journal, V13, P12
  • [10] Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas
    Choi, YL
    Kim, MK
    Suh, JW
    Han, J
    Kim, JH
    Yang, JH
    Nam, SJ
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2005, 20 (05) : 853 - 859